Tag: Johnson & Johnson MedTech
J&J to resume Varipulse cases following ‘voluntary pause’ of US external...
Following a temporary, voluntary pause of US external evaluation and all US cases with its Varipulse catheter, Johnson & Johnson (J&J) is set to...
Cardiac Rhythm News’ top stories of 2024
From first-time clinical data to major industry debuts, here are Cardiac Rhythm News’ 10 most popular stories of 2024.
1. Abbott joins the pulsed field...
Johnson & Johnson MedTech wins CE mark approval for dual energy...
Johnson & Johnson MedTech has announced European CE mark approval of the Dual Energy Thermocool Smarttouch SF catheter for the treatment of cardiac arrhythmias.
The...
J&J MedTech receives US FDA approval for Varipulse PFA platform in...
Johnson & Johnson (J&J) MedTech has announced the US Food and Drug Administration (FDA) approval of the Varipulse pulsed field ablation (PFA) platform for...
Cerenovus and Biosense Webster among brands newly incorporated into Johnson &...
Johnson & Johnson (J&J) recently shared that its medical technology businesses—including Cerenovus and Biosense Webster, as well as Abiomed, DePuy Synthes, and Ethicon—will now...